A BUDGET IMPACT MODEL FOR TIOTROPIUM/OLODATEROL VERSUS FIXED-DOSE COMBINATION TRIPLE THERAPY IN PATIENTS WITH COPD

被引：0
|
作者：
Palli, S. R. [1 ]
Clark, B. [1 ]
机构：
[1] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE493
引用
收藏
页码：S431 / S431
页数：1
相关论文
共 50 条
  • [31] The Clinical Implications of Triple Therapy in Fixed-Dose Combination in COPD: From the Trial to the Patient
    Luis Lopez-Campos, Jose
    Carrasco-Hernandez, Laura
    Roman Rodriguez, Lucas
    Quintana-Gallego, Esther
    Carmona Bernal, Carmen
    Alcazar Navarrete, Bernardino
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (04): : 242 - 248
  • [32] Cost-effectiveness of the fixed-dose combination tiotropium plus olodaterol based on the DYNAGITO trial results
    Hoogendoorn, Martine
    Ramos, Isaac Corro
    Baldwin, Michael
    Luciani, Laura
    Fabron, Cecile
    Detournay, Bruno
    Rutten-Van Molken, Maureen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [33] Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium plus Olodaterol
    Buhl, R.
    Tetzlaff, K.
    Korducki, L.
    Vogelmeier, C.
    McGarvey, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Triple Fixed-Dose Combination Therapy Back to the Past
    Black, Henry R.
    [J]. HYPERTENSION, 2009, 54 (01) : 19 - 22
  • [35] Effects Of 6 Weeks' Treatment With Once-Daily Tiotropium And Olodaterol Fixed-Dose Combination On Inspiratory Capacity And Exercise Endurance In Patients With COPD: The Moracto™ Studies
    O'Donnell, D.
    Casaburi, R.
    De Sousa, D.
    Xue, W.
    Frith, P.
    Hamilton, A.
    Kirsten, A.
    Maltais, F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] ANNUAL EXPENDITURES AMONG PATIENTS WITH COPD INITIATING TIOTROPIUM/OLODATEROL VS TRIPLE THERAPY
    Palli, Swetha
    Anderson, Amy
    Le, Lisa
    Buikema, Ami
    Franchino-Elder, Jess
    Frazer, Monica
    [J]. CHEST, 2021, 160 (04) : 1771A - 1772A
  • [37] Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination
    Rogliani, Paola
    Ritondo, Beatrice Ludovica
    Zerillo, Bartolomeo
    Cazzola, Mario
    Matera, Maria Gabriella
    Calzetta, Luigino
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 17 (02) : 215 - 223
  • [38] Clinical Usefulness of Once-Daily Triple Therapy, Ciclesonide and Tiotropium Bromide/Olodaterol Combination Inhaler for COPD Patients
    Masayuki, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [39] Controlled Prescription of Triple Fixed-Dose Combination Therapy in Spain
    Luis Lopez-Campos, Jose
    Peces-Barba, German
    Jimenez-Ruiz, Carlos A.
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (05): : 271 - 272
  • [40] Evaluation of Real-World Health Care Resource Utilization (HCRU) Among Patients with COPD Initiating Combination Tiotropium/Olodaterol Versus Triple Therapy
    Palli, S.
    Frazer, M.
    DuCharme, M.
    Buikema, A. R.
    Anderson, A. J.
    Elder, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345